JPRN-UMIN000051151尚未招募Unknown
Incidence and risk factors of serious infection in neuromyelitis optica spectrum disorders (NMOSD) patients: a retrospective cohort study using Medical Data Vision (MDV) database - Incidence and risk factors of serious infection in neuromyelitis optica spectrum disorders (NMOSD) patients: a retrospective cohort study using Medical Data Vision (MDV) database
适应症
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 入组人数
- 4,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The patients who have any record of prescription for the following drugs for the treatment of multiple sclerosis (MS) at any time point: - Interferon beta-1a, - Interferon beta-1b, - Ofatumumab, - Natalizumab, - Glatiramer acetate, - Dimethyl fumarate, - Siponimod fumarate, - Fingolimod hydrochloride.
研究者
相似试验
已完成
不适用
Incidence and risk factors of viral infections in patients after liver transplantatioPatients undergoing orthotopic liver transplantation from deceased donorsK74.6C22.0Other and unspecified cirrhosis of liverLiver cell carcinomaDRKS00006754Klinik für Anaesthesiologie Universitätsklinikum Heidelberg51
尚未招募
不适用
Incidence and risk factors for infectious diseases in long-term travelers: a prospective study.travel related infectious diseases10047438NL-OMON31962GGD Amsterdam600
尚未招募
Unknown
Risk factors for the development and severity of interstitial lung disease associated with EGFR tyrosine kinase inhibitors in non-small cell lung cancer: a systematic review and meta-analysisEGFR tyrosine kinase inhibitor-associated interstitial lung diseaseJPRN-UMIN000050523Showa University
招募中
4 期
Alteplase v.s. Trisodium Citrate and Infection and Obstruction Incidence of Permanent Tunneled Dialysis CathetersThe incidence of infection and obstruction of permanent tunneled dialysis cathetersinfection in dialysisRenal and Urogenital - Kidney diseaseACTRN12612000152820Pavlina Richtrova, MD, PhD80
已完成
不适用
To study benefits of betadine pessaries to prevent infective complication following TRUS guided prostate biopsyCTRI/2016/04/006843Dr Mahesh Behera260